Newsletter: September 2022
Following Landmark Achievement, California Psychedelic Decriminalization Bill Slated for 2023 Reintroduction September 22, 2022 On September 1, after California Senate Bill 519 (SB 519) was reduced to …
All News
ICPR 2022 Webinar: Amy Emerson, CEO of MAPS PBC
Summary: Amy Emerson, CEO of MAPS PBC, speaks at ICPR 2022 about how psychedelic-assisted therapy will become a reality and what the legislative and regulatory roadblocks will be. Watch the clip below. …
World Science Festival: Psychedelics: Chemicals, Consciousness, and Creativity
Summary: World Science Festival explores the potential impact of psychedelics on creativity, shifting perspectives, increasing connection, and healing medical conditions. In this video, MAPS Founder and …
UCLA Health: The Psychedelic RX
Summary: Researchers at UCLA and other University of California campuses are among a growing corps of scientists working to demonstrate the promise of hallucinogens to treat a variety of mental health …
The Washington Post: Psilocybin as Mental Health Therapy? Here’s What I Found.
Summary: Journalist Steven Petrow explores whether he’d like to use psilocybin as therapy for The Washington Post. Originally appearing here (Archived)
Following Landmark Achievement, California Psychedelic Decriminalization Bill Slated for 2023 Reintroduction
Senate Bill 519 would have decriminalized the personal possession of certain psychedelic substances, legalized life-saving public health interventions, and studied future approaches to increasing use of …
The Session with Tom Swarbrick Podcast: Psychedelic Therapy with Dr. Rick Doblin
Summary: In the newest episode of The Session, MAPS Founder and Executive Director Rick Doblin, Ph.D., speaks with host Tom Swarbrick about the history of MAPS, the scientific success of MDMA-assisted …
Reason: Julie Holland: ‘How You Can Feel Good, With or Without Drugs’
Summary: Julie Holland, psychiatrist and Good Chemistry author, speaks with Nick Gillespie of Reason about her newest book Good Chemistry: The Science of Connection from Soul to Psychedelics. Originally …
Newsletter: August 2022
MAPS, in Coordination with Allies, Assists U.S. Sentencing Commission in Reaching Quorum August 24, 2022 The middle of August brought an exciting milestone for MAPS! On August 17, we celebrated the appointment …
The Financial Times: Psychedelics are the Latest Employee Health Benefit
Summary: The Financial Times explores how ketamine-assisted therapy is gaining popularity with business leaders and the workplace as a viable health benefit for employees. MAPS Justice, Equity, Diversity …
MAPS, in Coordination with Allies, Assists U.S. Sentencing Commission in Reaching Quorum
United States Sentencing Commission, which establishes and advises Congress on federal sentencing guidelines, reaches first quorum in 3 years and a full slate for first time since 2014 Delayed appointments …
The Daily Beast: These Therapists Want to Help You Trip on Shrooms and Ecstasy
Summary: The Daily Beast explores research into MDMA and psilocybin treatments, highlighting promising study results, progress toward potential FDA approval, and the importance of equitable access for …